Lorne Cancer Conference has officially released the 2026 scientific program and opened registration for its 38th Annual Meeting, inviting cancer researchers from around the world to gather for an intensive and collaborative exchange of ideas.
Hosted in the coastal town of Lorne, along the iconic Great Ocean Road, Lorne Cancer 2026 offers a unique environment that combines cutting-edge cancer research with a setting designed to encourage discussion, reflection, and collaboration beyond the lecture hall.
A long-standing meeting with a strong scientific tradition
The Lorne Cancer Conference has built a strong reputation over nearly four decades for delivering high-quality international and national scientific content. Held immediately following the Lorne Protein meeting, the conference regularly attracts a capacity audience of up to 400 delegates, representing leading hospitals, universities, research institutes, and biotechnology companies across Australia and beyond.
Past participants consistently highlight the history, ambience, and intellectual vibrancy of the meeting, noting its ability to foster meaningful scientific exchange in a collegial and inclusive atmosphere.
A collaborative and industry-engaged environment
One of the defining features of the Lorne Cancer Conference is the open interaction between academic researchers, clinicians, and industry partners. The meeting has long promoted direct engagement with suppliers of laboratory equipment, reagents, and pharmaceuticals, supporting productive dialogue that bridges discovery research, translational science, and applied innovation.
This collaborative culture makes Lorne Cancer particularly valuable for early-career researchers as well as established investigators seeking feedback, partnerships, and fresh perspectives.
Leadership and organisation
The 2026 conference is co-convened by Jane Visvader and Wayne Tilley, both internationally respected leaders in cancer research. On behalf of the Organising Committee, the convenors invite participants to engage fully with the program, contribute to discussions, and take advantage of the unique opportunities the meeting provides.
The 2025 edition of the conference was again successfully managed by ASN, and the organising team looks forward to welcoming returning and first-time delegates to Lorne in 2026.
Registration, submissions, and sponsorship
- Registration for Lorne Cancer 2026 is now open, with full details available via the conference website.
- Researchers are encouraged to submit abstracts and contribute to the 2026 program, ensuring a diverse and dynamic scientific agenda.
- Sponsorship opportunities are limited and currently available for organisations wishing to engage directly with the cancer research community.
Acknowledgement of Country
The Lorne Cancer Conference acknowledges Aboriginal and Torres Strait Islander peoples as the First Peoples and Nations of Australia, recognising their deep spiritual connection to Country and paying respect to Elders past, present, and emerging.
Join the Lorne Cancer community
Lorne Cancer 2026 offers more than a conference—it is a space to share ideas, build collaborations, and recharge intellectually in a setting that supports both scientific excellence and personal connection. Researchers at all career stages are invited to take part in this landmark meeting in the cancer research calendar.